TLSI Q4 2024 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8M+44.4% YoY

Gross Profit

$7M85.3% margin

Operating Income

-$8M-91.8% margin

Net Income

-$10M-122.4% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

+12.4%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$24M

Total Liabilities

$50M

Stockholders' Equity

-$26M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$6M	+44.4%
Gross Profit	$7M	$5M	+37.1%
Operating Income	-$8M	-$14M	+46.3%
Net Income	-$10M	-$36M	+71.5%